IROS and Halia Therapeutics’ clinical trial will explore a promising new therapy for obesity, specifically designed to ...

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and improved asthma management.

GLP-1 receptor agonist, or GLP-1 RA, drugs help treat diabetes by weight loss, improving blood glucose levels and increasing ...

For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

It's no secret that Ozempic isn't going anywhere, but the weight loss drug category does seem to be rapidly evolving.

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

As a reader of the news, you already know that West Virginia in most years remains in last place or near last place for ...

If you’re already have trouble keeping a New Year’s resolution, your location may be setting you up for failure, according to ...

South Australia has become the first Australian state or territory to ban junk food advertisements on public transport in a bid to curb childhood obesity. Here's what people are saying.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...